|
|
Vol. 53, No. 4, April 2007, pp.672 - 677 Copyright © 2007 by The College of Family Physicians of Canada
Asthma control in CanadaNo improvement since we last looked in 1999R. Andrew McIvor, MD MSc FRCPCProfessor of Medicine at McMaster University and a Respirologist in the Firestone Institute for Respiratory Health at St Josephs Healthcare in Hamilton, Ont
Louis-Philippe Boulet, MD FRCPC
J. Mark FitzGerald, MB FRCPI FRCPC
Sabrina Zimmerman
Kenneth R. Chapman, MD FACP FRCPC
Correspondence to: Dr Andrew McIvor, Room T2127, Firestone Institute for Respiratory Health, St Josephs Healthcare, 50 Charlton Ave E, Hamilton, ON L8N 4A6; telephone 905 522–1155, extension 4330; fax 905 521–6183; e-mail amcivor{at}stjosham.on.ca Studies conducted in Canada,1,2 the United States,3 Europe,4 and the Asia-Pacific area5 suggest that asthma is not well enough controlled around the world. This situation exists despite the availability of effective medications and several national, evidence-based asthma treatment guidelines,6–8 including versions published during the past 15 years in Canada.9–13 To improve the situation, a Quebec group proposed a model of automatic referral to asthma education centres for patients who came to emergency departments for acute asthma.14 This model significantly increased the number of patients who could benefit from educational intervention. In a British Columbia study,15 a health coordinator made follow-up appointments with patients family physicians after these patients had been to emergency departments for asthma. This strategy resulted in significantly more follow-up office visits, produced more written action plans, and improved quality of life for patients 6 months after the intervention compared with patients who received usual care. Because increased use of guidelines might improve asthma care, efforts to disseminate Canadian guidelines were stepped up with the 2001 update.12 Dissemination strategies included mailing the guidelines to physicians and maintaining a website that had the guidelines, information for patients, and other downloads.16 Our survey, The Reality of Asthma Control (TRAC),17 was designed to update 2 earlier Canadian surveys of patients1,2 to see whether new medications and guideline-implementation strategies had had any effect. It was also designed to enrol a larger patient sample than either of the previous studies,1,2 and unlike the survey conducted in 1999,2 it enrolled only adults. The null hypothesis was that the degree of asthma control had not changed in the last years despite efforts to improve care. This article reports on our findings regarding asthma control, knowledge about asthma, and use of health care resources when asthma worsens.
Patient telephone survey An independent consumer-research company (ICOM Information & Communications Inc, Toronto, Ont) provided the national patient sample frame. In April 2004, trained survey staff from Environics Research Group in Toronto telephoned 26 210 Canadian households that contained at least 1 person with asthma. Patients eligible for inclusion were 18 to 54 years old, had been diagnosed with asthma by a physician at least 6 months previously, did not have chronic obstructive pulmonary disease, and had a smoking history of fewer than 20 pack-years. Identification of cases that met these inclusion criteria depended solely on patients self-reports. At least 5 telephone calls were made to a household before it was classified as "no answer." When a household had more than 1 qualified person, the subject was chosen according to the most recent birthday method. Interviews were allocated according to flexible regional quotas, which were raised in the field to increase the number of completed surveys in regions with smaller populations. A companion paper provides additional details on sample-size determination and regional quotas.17 We developed a telephone survey questionnaire, which took about 35 minutes to complete, in conjunction with the research company. The patient survey was pretested on 14 patients and was further refined after the completion of 89 interviews. There was no further measurement of the surveys validity and reliability.
Physician survey
Definitions The survey defined asthma "worsening" as a time when asthma was at its worst (most out of control) or when symptoms worsened substantially. Asthma "exacerbation" was defined as an episode that required acute care (unscheduled physician visit, emergency department visit, or overnight hospitalization).
Analysis and ethics approval
Table 1 lists the number of patients at each stage of the recruitment and interview process. The effective completion rate for the telephone interviews was 7%, and the actual completion rate was 13% (Table 1). Table 2 presents demographic information.
Asthma control According to the objective criteria of the Canadian Asthma Consensus Guidelines,11–13 474 of the 893 patients (53%) had uncontrolled asthma, and 418 (47%) had controlled asthma. (The number of patients adds to 1 less than the total of 893 patients; 1 patient could not be classified because of "dont know" responses or no answers to questions on asthma control.) Only 3% of patients thought they had uncontrolled asthma (Table 3).
Among patients who claimed their asthma was well controlled, few could describe aspects of good control. According to 45% of patients, making 1 or 2 visits to an emergency department was an expected part of having asthma.
Worsenings and exacerbations
Asthma education
Hospitalization rates and asthma mortality rates among adults with asthma declined substantially in Canada between 1987 and 2000.19 Nevertheless, TRAC demonstrates that asthma control remained suboptimal in Canada 5 years after the last large national survey. The 53% of patients who reported they had uncontrolled asthma in TRAC is consistent with results of earlier Canadian studies. In 1999, 57% were uncontrolled (measured by the same criteria as in TRAC),2 and in 1996, 55% of patients reported daily symptoms.1 The TRAC results suggest that patients, physicians, or both fail to recognize the potential seriousness of exacerbations and emergency department visits for acute asthma. These episodes increase the risk of severe asthma events (including death) for patients who have had repeated or recent periods of worsening asthma,20 decrease quality of life,21 and increase the burden on the health care system. 22
The key limitation of the TRAC study is that data were collected retrospectively, so could be subject to recall bias. In addition, the surveys definition of "asthma exacerbation" was somewhat arbitrary, because patients might have treated exacerbations according to their asthma action plan instructions and not gone to see physicians. The high prevalence of emergency department visits suggests that these episodes of worsening asthma were in fact real, serious events, so our study limitations would be more likely to lead to under reporting of worsening asthma than over reporting. Another potential bias stems from the low response rate to the survey, which took about half an hour to complete. We speculate that the length of the survey largely accounted for this. Because respondents who did make the time to answer the survey might have been more knowledgeable or interested than most patients about asthma, the results might not accurately reflect the state of asthma control in Canada.
Little has changed in control of asthma over the last decade in Canada according to results of community surveys and to public health experts. As part of its ongoing effort to change the situation, the Canadian Thoracic Societys Asthma Committee is planning to update the Canadian asthma guidelines. We suggest that TRAC results are as important for review and reflection as is efficacy data from clinical trials. In partnership with community-based family physicians and urgent care providers, the committee hopes to develop such things as asthma care maps and standing orders to foster changes in community practice based on evidence. These initiatives, researching best practices in continuing medical education, and encouraging patients to adhere to their prescribed treatment regimens (pharmacotherapy and routine follow up) might help improve asthma control. By fostering partnerships and improving control, we believe we can reduce urgent care visits and improve asthma control in Canada.
Environics Research Group developed the survey instruments in conjunction with the authors, conducted the surveys, and analyzed the results. IntraMed provided editorial assistance for this manuscript. A grant from AstraZeneca Canada funded the survey.
This article has been peer reviewed. Dr McIvor, Dr Boulet, Dr FitzGerald, Ms Zimmerman, and Dr Chapman contributed to study concept and design, analysis and interpretation of data, and preparing the article for submission. Dr Boulet has received honoraria, lecture fees, research sponsorship, funding for participating in asthma treatment studies, or support for producing educational materials from 3M, Altana, Asthmatx, AstraZeneca, Boehringer-Ingelheim, Dynavax, Genentech, GlaxoSmithKline, IVAX, Merck Frosst, Novartis, Roche, Schering, and Topigen. Dr FitzGerald has received funding from AstraZeneca for research, for participating on advisory boards, and for presenting continuing health education seminars.
Related articles in CFP:
This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||